Reach Us +44-1647-403003
Lung Cancer: Early Diagnosis and Screening | OMICS International | Abstract
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Rapid Communication

Lung Cancer: Early Diagnosis and Screening

David R Baldwin1* and Richard B Hubbard2

1Consultant Respiratory Physician, Nottingham University Hospitals and Honorary Associate Professor, University of Nottingham, Respiratory Medicine Unit, David EvansCentre, UK

2GSK/BLF Professor of Respiratory Epidemiology, University of Nottingham, Clinical Sciences Building, Nottingham City Hospital, UK

*Corresponding Author:
Dr. David R Baldwin
Consultant Respiratory Physician
Nottingham University Hospitals and Honorary Associate Professor
University of Nottingham, Respiratory Medicine Unit
David Evans Centre, Nottingham City Hospital Campus
Tel: 0115 9691169 (ext 57462)
Fax: 0115 9627723
E-mail: [email protected]

Received date: December 19, 2011; Accepted date: February 02, 2012; Published date: February 06, 2012

Citation: Baldwin DR, Hubbard RB (2012) Lung Cancer: Early Diagnosis and Screening. J Cancer Sci Ther S7:002. doi:10.4172/1948-5956.S7-002

Copyright: © 2012 Baldwin DR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Lung cancer accounts for an estimated 1.4 million deaths globally that is, 18.4% of all cancer deaths. More than 35,000 people died from lung cancer in 2008 in the UK. In males this was almost a quarter of all cancer deaths and in females just over a fifth. By comparison, 16% of female cancer deaths were from breast cancer and the second commonest cause of cancer death overall (colorectal) accounts for 10% of all cancer deaths. The majority of people with lung cancer (three quarters in the UK) present with stage IIIb or IV disease where cure is impossible and so survival low in comparison with other common cancers.
There are two ways in which we are likely to diminish the huge public health burden that mortality from lung cancer constitutes: smoking cessation and earlier diagnosis. Smoking cessation has already produced dramatic falls in the age-adjusted incidence of lung cancer and it appears that lung cancer incidence has passed its peak in males at least. Continued efforts to reduce the prevalence of smoking across all sectors of society are a key public health priority. However there remains a large population at risk of developing lung cancer. In the US in 2007 there were an estimated 94 million people with a history of smoking and about half of these were current smokers. Thus the second way mortality may be substantially altered by early detection initiatives that lead to diagnosis at an earlier stage. There are, in turn, two ways in which people may be diagnosed earlier: by the use of early diagnosis and awareness initiatives and by population screening. The first of these methods is unproven and the second has only recently been shown to be effective.

Share This Page